CS Paper Radar

When Should AI Decide, Defer, and Deviate? Responsible Automation for Deceased Donor Kidney Allocation

Madeleine Pollack, Thomas Daillak, Mehmet Toner, Korkut Uygun, Heidi Yeh, Swati Gupta

cs.AI ·submitted 2026-10-28 23:17 UTC · v1
unusual

Abstract

We ask when an AI trained on historical decisions should be allowed to recommend decisions, defer to human experts, or in other cases, flag concerning patterns in data and deviate from past practice. This can be challenging because past decisions record what was done rather than what should have been done, and where data is sparse, a model's predictions may be too uncertain to act on. We provide a framework for addressing this problem using a case study in deceased-donor kidney allocation. Nearly 30% of kidneys recovered from deceased donors in the United States are never transplanted, largely because they are hard to place through the standard waitlist sequence. One can use AI to flag kidneys at risk of delayed or failed placement for out-of-sequence (OOS) allocation, but this comes at the cost of bypassing candidates higher on the waitlist. Thus, OOS allocation should only be used when the organ is demonstrably at high risk of discard on the standard sequence. Using Organ Procurement and Transplantation Network match-run data from 2016-2019 and 2023-2025 (excluding COVID-19-disrupted years), we build the Arbitrator framework, which combines various interpretable models and acts only when the uncertainty in their predictions cannot change the preferred action. Our Arbitrator resolves 93.5% of organ placement decisions using explicit medical criteria learned from data, and defers the remaining 6.5% to a human or a more complex model. We show that the Arbitrator correctly identifies 70.1% of historically discarded low-KDPI kidneys as OOS candidates, projecting that up to 43.9% of historically discarded kidneys could be flagged for expedited placement and potentially transplanted. We then exploit the interpretability of the Arbitrator to create an agentic audit comparing the learned rules to published clinical literature in order to flag decision-making patterns that are contentious.

Closest papers

Nearest neighbours by meaning across the whole index.

Kidney Exchange with Dual Donors

cs.GT ·2026-10-30 ·Ioannis Caragiannis, Tomasz Filip Gawron, Kristoffer Arnsfelt Hansen, Yuchen Zhang
similarity 0.56
Abstract

Kidney exchange programs enable patients with incompatible living donors to receive transplants by exchanging donors with other patient-donor pairs. Existing models typically assume either that each patient enrolls with a single donor, or that at most one of a patient's multiple alternative donors is selected to donate. In practice, however, a patient may have access to multiple willing but incompatible donors who are all prepared to donate simultaneously if doing so enables the patient to receive a kidney. We study a dual-donor kidney exchange model, in which a patient may enroll with up to two proxy donors and the exchange is allowed to utilize both, provided the patient receives a compatible transplant. This paradigm allows a patient to participate in an exchange cycle via one donor while their second donor initiates a donation chain---unlocking additional transplants without relying on altruistic donors. We formulate the resulting combinatorial optimization problems under realistic cycle and chain constraints, showing that utilizing both donors introduces sharp computational challenges compared to standard exchange, and we design new approximation algorithms with provable guarantees. We also study strategic manipulation when patients hide a donor, establishing the limits of deterministic mechanisms and showing how randomization achieves truthfulness with near-optimal welfare. Finally, our experiments on realistic synthetic graphs demonstrate that using both donors yields substantial gains in total transplants over selecting at most one---even when only a small fraction of patients enroll with two donors.

0.30

Dynamic Pooling and Regional Participation in Deceased-Donor Organ Allocation

cs.GT econ.TH ·2026-09-16 ·Genta Okada
unusual similarity 0.54
Abstract · 47 pages, 3 figures

Moving from geographically fragmented to pooled waiting lists in deceased-donor organ transplantation can improve efficiency, but it raises concerns about regional fairness and participation incentives. This paper studies Pareto gains from such transitions in a multi-class queueing model with impatient agents, perishable items, and a tractable homogeneous compatibility friction. In contrast to standard approaches that emphasize static match quality or overlook regional incentives in dynamic contexts, this analysis identifies dynamic risk pooling as the primary source of Pareto improvements for regions. Pooling reduces organ waste resulting from stochastic supply-demand fluctuations, temporal mismatches, and random compatibility outcomes. Although this dynamic surplus theoretically enables Pareto improvements, a purely utilitarian policy that treats all patients equally across regions often fails to achieve these improvements when regions are asymmetric. In these situations, utilitarian redistribution removes an excessive number of organs from high-supply regions and violates their participation constraints. To address this conflict, it is demonstrated that the set of achievable utilities can be represented by mixtures of static priority index policies. Building on this structure, the Constrained Pareto Frontier Search (CPFS) is proposed as a polynomial-time procedure that computes an approximately optimal allocation policy with arbitrarily small participation-constraint violations. The results indicate that, by adjusting priority indices to ensure redistribution remains within the gains from pooled supply, demand, and compatibility risk, policymakers can achieve global efficiency while maintaining local participation incentives.

0.29

SMARtCARE: Privacy-Preserving Agentic AI Systems for Bounded-Autonomy Clinical Decision Support

cs.AI cs.ETcs.SE ·2026-09-24 ·Srini Ramaswamy, Deveeshree Nayak
published similarity 0.53
Abstract · Paper accepted to, and to appear in, the 2026 IEEE HealthCom Conference

Long-context clinical AI systems can miss relevant patient history when prior admissions fall outside the active reasoning context. In ICU monitoring, this can cause early vital-sign drift to appear nonspecific even when it resembles a prior deterioration pattern. SMARtCARE addresses this gap through a four-state clinical decision-support architecture: Stable, Meta-cognitive, Assisted, and Regulated (Revoked). Rather than automatically retrieving prior records, SMARtCARE uses a lossy six-channel fingerprint of the patient's prior trajectory. When current drift matches that fingerprint and the prior record is absent from context, the system raises a Meta-cognitive escalation for clinician review; full retrieval occurs only through clinician action in the Assisted state. A patient-identity guard is designed to enforce correct attribution across data loading, logging, and audit layers. Evaluation combines a synthetic Monte Carlo study that validates the state-transition logic and estimator stability, not clinical performance, with real-data runs on both the MIMIC-III and MIMIC-IV Clinical Database Demos. On MIMIC-III, one prior-pattern recurrence was identified among 14 two-admission patients; on MIMIC-IV, the same pipeline produced no fingerprint matches among 9 two-admission patients, which illustrates a key limitation of a fixed canonical pattern library. Across both runs all logged decisions were fully traceable and correctly attributed. The results support SMARtCARE as a traceable, privacy-aware mechanism for surfacing middle-context risk; they are not a clinical efficacy claim.

0.25

Anticipating or Speculating? Making Futures Pay in AI Ethics

cs.CY cs.AI ·2026-11-17 ·John P. Nelson
similarity 0.53
Abstract

Philosophers have recently been trying to develop uniform decision rules for instances in which physicians' judgments diverge from the recommendations of medical artificial intelligence (AI) systems. I argue that this effort is fatally flawed because the performance and appropriate use of algorithmic recommendation systems by physicians are highly context-specific, empirical medical matters rather than epistemological ones. In such instances, general decision rules can be stipulated only to the extent that they abstract away from relevant, indeed determinative, contextual circumstances. The alleged problem of physician-AI disagreement, and others like it, play into longstanding disputes in technology ethics about the viability and utility of envisioning possible futures: is this useful "anticipation" or wasteful "speculation"? I suggest that the two may be distinguished. Anticipation explores plausible futures to help inform present actions under irreducible uncertainty. Speculation abstracts away uncertainty, developing formal solutions to stipulated circumstances whose relationship to the real present is often quite unclear. Efforts to develop crisp philosophical solutions to physician-AI disagreement, among other problems, fall into the latter category. Technology ethics should remember that fruitful futures thinking must both begin from and return to the messy, uncertain present.

0.26

Evidence-Anchored Overdose Death Prediction from Death Investigation Reports

cs.CL cs.AIcs.LG ·2026-10-14 ·Raavi Gupta, Ziqing Yang, Karli R. Hochstatter, Talia Nadel, Nicole D'Anna +6 more
similarity 0.53
Abstract

Confirmation of overdose deaths in the United States is often delayed due to the complexities of certifying drug-involved deaths. Death investigation reports represent a rich but underutilized data source that could be used to predict whether a death is a suspected overdose (i.e., a death preliminarily identified as an overdose prior to the final cause and manner of death determination). We present an automated framework that classifies suspected overdoses from death investigation reports, while producing supporting explanations guided by expert knowledge. Through an expert-guided design process, we investigate 1) what type of explanations are best for model prediction performance, and 2) which architecture is better suited for this task: pipeline models that rationalize first and then predict, or self-rationalizing models that jointly predict and rationalize? Our experiments show that a pipeline model with explanations grounded in the input death investigation reports outperforms the other settings. Our best model also outperforms a rule-based system currently in deployment by 15%, while allowing expert interventions for final decisions.

0.16

Review Before Trust: Source-Grounded Integrity Gates for AI-Assisted Personal Health Records

cs.AI ·2026-08-30 ·Nora Girda, Adrian Groza
similarity 0.52
Abstract

Large language models can convert medical documents into structured data, but plausible output may still be unsupported by the source. Persisting such output in a longitudinal health record, a record that accumulates patient information over time, therefore creates an integrity risk: unverified data may influence later summaries, trends, or preventive-care computations. We introduce an evidence-gated trust-promotion model that keeps generated data provisional until a deterministic monitor verifies it against the source document. The monitor admits a candidate for a specified downstream use only when the source contains a unique supporting quotation, the relevant fields occur within the same laboratory row, and the required provenance is preserved. The generator cannot approve its own output, missing or ambiguous evidence causes refusal, and refused candidates remain available for human review rather than being silently discarded. We implement the model in Medical DataCloud, a personal health-record application, and evaluate it through automated tests and a replay of saved extraction outputs. All 22 conformance and mutation tests pass. The replay covers nine historical laboratory PDF reports containing 102 manually labelled rows. The reports produce 97 numeric candidates: schema validation accepts all 97, an earlier packet-level evidence check accepts 94, and the hardened quotation- and row-level policy admits 72 while retaining 25 for review. The study evaluates system integrity rather than clinical correctness or clinical safety. The results demonstrate the technical feasibility of an enforceable boundary that prevents generated claims from authorizing their own reuse in a longitudinal health record.

0.21

When Clinical Judgment Becomes a Predictive Shortcut: Two Questions Clinical AI Must Answer Before Deployment

cs.AI ·2026-09-22 ·Jing Yang, Long R. Jiao, Zongjiu Zhang, Xiujun Cai
similarity 0.52
Abstract · 27 pages, 1 figure, 3 tables, 1 box; includes Multimedia Appendix 1

Clinical AI can predict outcomes using information generated by existing clinical judgment. Such performance alone cannot establish usefulness before recognition or across care processes. We propose evidence requirements matched to intended use and information conditions, with additional state-reference and proxy-relative timing tests for stronger recognition claims. This framework helps hospitals assess whether the conditions supporting performance hold when assistance is most needed. These questions remain outside current evaluation practice leakage checks, overall predictive performance, and external validation do not address them; the framework makes them explicit and specifies the direct evidence required to answer them.

0.19

"It's still 100% on me": Designing AI Tools for the Intersection of Physicians' Care and Legal Infrastructures

cs.HC ·2026-11-11 ·Gennie Mansi, Julia Kim, Lynn Dombrowski, Mark Riedl, Naveena Karusala
similarity 0.52
Abstract · 27 pages, 0 figures

Laws and regulations deeply shape physicians' workflows and impact how they incorporate AI-based decision support tools to care for patients. Despite calls to comply with legal standards, many AI-based decision support tools have not transitioned well to clinical settings. The medical community remains concerned about their legal liability, risks to patients, and limited clinical value of such tools. To better understand how to address these concerns in the design of AI tools for clinical decision-making, we conducted 19 interviews with physicians in the U.S. We used scenario-based design to investigate physicians' legal concerns in the context of an AI-based drug recommendation tool. Drawing on the ethics of care, we surface connections between physicians' care and the healthcare laws and regulations that deeply shape their information needs. We describe how physicians wanted to use the tool in individual and collective practices to care for themselves, their patients, their colleagues, work institution, and even the broader medical profession. We discuss how the design of AI-based decision support tools can present legal ambiguities that would prevent their caring actions and lead to non-use of the AI tool. Through our work, we contribute to responsible AI development in healthcare. Our analysis illuminates why and how certain kinds of information reduce legal ambiguity and support physicians' care when using AI-based decision support tools. We contribute an understanding of how to help physicians navigate legal liability and draw implications for grounding AI tools' designs in their care.

0.37